Homeopathic Drug Product Safety, Quality, and Transparency Act
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to homeopathic drug products, and for other purposes.
The bill SB4692 aims to update regulations for homeopathic drugs under the Federal Food, Drug, and Cosmetic Act. Homeopathic drugs are medications that are highly diluted and are often used as alternative treatments. The proposed changes focus on ensuring these products are safe, of high quality, and that information about them is transparent.
This bill would impact manufacturers and consumers of homeopathic drugs. If passed, it would likely lead to stricter guidelines for the production and labeling of these products, potentially making them safer and easier to understand for consumers. It may also affect how these products are marketed and sold.
As of the last update on June 4, 2026, the bill was introduced and referred to the Senate Committee on Health, Education, Labor, and Pensions for further review. This means that the committee will examine the bill's details, hold hearings if necessary, and decide whether to recommend it for further action in the Senate.
